HR 4752 · Reducing Hereditary Cancer Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced
- Jul 23, 2025
- Latest action
- Jul 23, 2025
- Sponsor
- Rep. Debbie Wasserman Schultz [D-FL-25]
- Policy area
- Health
- Cosponsors
- 27
Summary
Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Recent actions
- Jul 23, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jul 23, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jul 23, 2025 Introduced in House
- Jul 23, 2025 Introduced in House
Votes
No recorded votes are available for this bill.